NCT06485076
- Conditions
- Aggressive Lymphoma, B Cell Lymphoma, Blood Protein Disorders, +22 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
Clinical trial condition
Explore clinical trials studying Multiple Myeloma Stage III. Study availability and eligibility vary by location and protocol.
NCT06485076